InsiderTrades

Form 4 for TECX Tectonic Therapeutic, Inc.

Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0002023175-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-12 2026-02-10 TECX Schwabish Marc Chief Business Off M - OptEx $2.38 +4,500 25.8K +21% +$10.7K
D 2026-02-12 2026-02-10 TECX Schwabish Marc Chief Business Off M - OptEx — -4,500 82.0K -5% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-10 M A 4,500 $2.38 25,814 D — —
2 Derivative Employee Stock Option (Right to Buy) 2026-02-10 M D 4,500 — 82,014 D $2.38 · — to 2031-06-27 4,500 Common Stock (F2) Received in exchange for a stock option to acquire 170,679 shares of Tectonic common stock pursuant to that certain merger, as more specifically described in the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017972/xslF345X05/form4-06242024_080616.xml (F1) The shares subject to the option vest as to 25% of the shares on March 15, 2022 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.